Choppy waters: The importance of accounting for shifting drug utilization during the COVID-19 pandemic in future observational drug-related studies

Basic Clin Pharmacol Toxicol. 2021 May;128(5):649-651. doi: 10.1111/bcpt.13568. Epub 2021 Feb 19.

Ahmad Shakeri¹, Tara Gomes^{2

3

4}, Katie Suda^{5

6}, Mina Tadrous^{1

3}

¹ Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.
² Unity Health Toronto, Toronto, ON, Canada.
³ Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.
⁴ Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
⁵ Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.
⁶ Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.

No abstract available

Keywords: COVID-19; drug utilization; pharmacoepidemiology; pharmacovigilance; research design.

MeSH terms